cocktails are the best
This information is based upon single entity administration of herceptin. The real benefit of this drug is when given with chemo. As well, there has been great results in herceptin + lapatinib administration. The desire for her2 receptors to off-load onto her1 receptors probably accounts for that 30% you mention. That's why there is research into multi-targetted therapies such as herceptin + lapatinib or iressa or tarveca; and herceptin + avastin; herceptin + faslodex; etc.
Don't be discouraged, just find out what works for you and go for it.
Cheers,
Al
__________________
Primary care-giver to and advocate for Linda, who passed away April 27, 2006.
|